METTL13 / KIAA0859 Antibody

LifeSpan BioSciences

METTL13 / KIAA0859 Antibody

23

The predicted MW is 44kDa/61kDa/68kDa/72kDa/78kDa, while the observed MW by Western blot was 85kDa.

ImmunoFluorescence, Western Blot, ImmunoHistoChemistry

IF (1:50 - 1:100), IHC (1:50 - 1:100), WB (1:500 - 1:2000) The predicted MW is 44kDa/61kDa/68kDa/72kDa/78kDa, while the observed MW by Western blot was 85kDa.

Research Use Only

Polyclonal

Unconjugated

...

METTL13

methyltransferase 13, eEF1A lysine and N-terminal methyltransferase

5630401D24Rik; antiapoptotic protein FEAT; CGI-01; deafness (autosomal recessive, nonsyndromic) modifier 1; deafness (recessive, nonsyndromic) modifier 1; deafness (recessive, non-syndromic) modifier 1; DFNB26; DFNB26M; DFNM1; eEF1A lysine and N-terminal methyltransferase; EEF1AKNMT; eEF1A-KNMT; faint expression in normal tissues, aberrant overexpression in tumors; feat; KIAA0859; methyltransferase like 13; methyltransferase-like protein 13

Rabbit

IgG

-20°C

12352203